INCB053914 is a pan-PIM inhibitor that can work by blocking specific chemicals in the cancer cell that block some cells from dividing and growing.
|Developed By||Incyte Corporation|
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
There are no resources, links or videos to display for this treatment.